Stocks of Chimerix Inc (CMRX) are poised to climb above their peers

With 1.92 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.07 million shares. The 52-week range on CMRX shows that it touched its highest point at $5.53 and its lowest point at $0.75 during that stretch. It currently has a 1-year price target of $9.40. Beta for the stock currently stands at 0.33.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CMRX was up-trending over the past week, with a rise of 1.94%, but this was up by 28.99% over a month. Three-month performance surged to 488.63% while six-month performance rose 434.30%. The stock gained 335.68% in the past year, while it has gained 50.86% so far this year. A look at the trailing 12-month EPS for CMRX yields -0.94 with Next year EPS estimates of -0.86. For the next quarter, that number is -0.26. This implies an EPS growth rate of -6.55% for this year and 13.41% for next year. EPS is expected to grow by 11.98% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 8.31%.

Float and Shares Shorts:

At present, 89.94 million CMRX shares are outstanding with a float of 76.06 million shares on hand for trading.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.95092 being high and -$1.031 being low. For CMRX, this leads to a yearly average estimate of -$0.99096. Based on analyst estimates, the high estimate for the next quarter is -$0.29 and the low estimate is -$0.29. The average estimate for the next quarter is thus -$0.29.